Pilgrim's Pride Corporation produces, processes, markets, and distributes fresh, frozen, and value-added chicken and pork products to retailers, distributors, and foodservice operators in the United States, Europe, and Mexico.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.76, read 2026-11-05
Ethical passes the values gate
Price28.62 USD
Fair value38.75
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-11-04Read Markup27.28+4.9% to today ✓Distribution gives way to Markup first Markup read since October
2026-10-28Read Distribution28.22+1.4% to today Markup gives way to Distribution first Distribution read since October
2026-10-23Read Markup28.22+1.4% to today ✓Distribution gives way to Markup after a 12% rise in 12 days
2026-10-11Read Distribution25.20+13.6% to today Markdown gives way to Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Pilgrim's Pride Corporation holds its Markup at $28.62. The statistical read favours the buyers, held for 22 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 22 days
Price at the screen
$28.62
Valuation
21.65 trailing · 11.42 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.35
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
32.42%
Below 33%
Interest-bearing debt is just 32.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
16.91%
Below 49%
Money owed to the company is 16.9% of assets, under the 49% limit.
Pass
Revenue purity
0.28%
Below 5%
Only 0.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Pilgrim's Pride clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 32%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PPC's ethical verdict changes
Today PPC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 26% discount to our $38.75 fair value.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 26.1% discount to the base estimate.
Where our models see it going: fair-value estimate $38.75, with a range of $38.10 to $57.24, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Chicken processor priced for thin returns only
Every supermarket fillet or fast-food nugget passes through processors that turn grain into packaged meat. This one moves fresh and frozen chicken and pork across the US, Europe and Mexico, posting 26 percent ROE on 5 percent margins while revenue edges up just 2 percent a year.
The 9.2 times forward earnings multiple looks attractive at first glance, yet the 4 percent margin of safety to fair value leaves almost no room for error. With an opportunity rating of none and analysts clustered around a hold call near 32 dollars, the business fails to clear the bar for anything beyond average cyclical exposure.
Feed-cost swings and shifting demand can erase profits overnight in this industry, turning low multiples into classic value traps rather than bargains. The ethical screen passes, but that alone does not offset the limited growth and thin cushion.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PPC trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markup · changed$27.28-3.3%Entry 17
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markup$28.22+0.0%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markup$28.22+0.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markup$28.22+0.0%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markup$28.22+0.0%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markup · changed$28.22+0.0%Entry 11
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Distribution$28.22+0.0%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Distribution$28.22-2.3%Entry 9
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Distribution$28.89+14.6%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 14.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (8 analysts) rates it buy, with a mean price target of $39.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
